Biomarkers

C-terminal of type XXII collagen. FACIT collagen measuring tissue formation, molecular bridging and tissue organization. A fragment of the C-terminal domain of type XXII FACIT collagen, enabling non-invasive monitoring of extracellular matrix organization, molecular bridging and tumor-associated fibrosis across multiple solid tumor types.

A fragment of the 7S domain of type IV collagen, enabling non-invasive monitoring of basement membrane formation and epithelial extracellular matrix remodeling in fibrotic and inflammatory diseases.

A fragment of the C-terminal domain of type VII collagen, the only anchoring fibril, enabling non-invasive monitoring of dermal-epidermal junction integrity and extracellular matrix formation in skin and intestinal tissue remodeling.

A fragment of the NC1 domain of type VIII collagen, enabling non-invasive monitoring of epithelial basement membrane remodeling and tumor-associated fibrosis in solid tumors.

A fragment of the NC1 domain of type IX FACIT collagen, enabling non-invasive monitoring of extracellular matrix remodeling in various solid tumors.

A fragment of the C-terminal end of fibrinopeptide A, enabling non-invasive monitoring of coagulation-driven fibrotic activity in inflammatory and fibrotic conditions.

A serine protease-mediated fragment generated after cleavage and release from the N-terminal of PAR2, enabling non-invasive monitoring of PAR2 activation and associated inflammatory processes in rheumatic diseases.

Blood-based detection of tau phosphorylated at threonine 217, enabling minimally invasive assessment of neurodegenerative pathology

A matrix metalloproteinase-generated fragment of SPARC, reflecting extracellular matrix remodeling and tissue remodeling activity.

A fragment of tau generated by ADAM10, enabling non-invasive monitoring of cognitive decline and neuronal degeneration in neurodegenerative diseases.